Pembrolizumab for NSCLC: Immune-mediated adverse events and corticosteroid use Meeting Abstract


Authors: Leighl, N.; Gandhi, L.; Hellmann, M. D.; Horn, L.; Ahn, M. J.; Garon, E. B.; Hui, R.; Ramalingam, S. S.; Zhang, J.; Lubiniecki, G.; Raftopoulos, H.; Hamid, O.
Abstract Title: Pembrolizumab for NSCLC: Immune-mediated adverse events and corticosteroid use
Meeting Title: 16th World Conference on Lung Cancer (WCLC)
Keywords: pembrolizumab
Journal Title: Journal of Thoracic Oncology
Volume: 10
Issue: 9 Suppl. 2
Meeting Dates: 2015 Sep 6-9
Meeting Location: Denver, CO
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S233
Language: English
ACCESSION: WOS:000370365100387
PROVIDER: wos
PUBMED: 26710300
DOI: 10.1016/S1556-0864(16)30010-7
Notes: Meeting Abstract: ORAL31.02 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    412 Hellmann